María Pilar
Garrido López

Profesor/a Asociado/a en CC. de la Salud

Foto de María Pilar

Foto de Hospital Son Llàtzer

Hospital Son Llàtzer

Palma, España

Publications in collaboration with researchers from Hospital Son Llàtzer (5)

2024

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789

2021

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer, Vol. 21, Núm. 1

2020

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study
BMC Psychology, Vol. 8, Núm. 1

2016

Lung cancer in women with a family history of cancer: The Spanish female-specific database WORLD07
Anticancer Research, Vol. 36, Núm. 12, pp. 6647-6653

2012

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246